Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 8/2004

01.08.2004 | Original Paper

Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics

verfasst von: Yan Li, Bo Tian, Jiong Yang, Lei Zhao, Xin Wu, Sheng-Long Ye, Yin-Kun Liu, Zhao-You Tang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 8/2004

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To establish a “stepwise metastatic human hepatocellular carcinoma (HCC) cell model system” for in-depth study of the underlying mechanisms of HCC metastasis.

Methods

Using MHCC97— a metastatic human hepatocellular carcinoma (HCC) cell line reported in 1999—as the parent cells, we subsequently established three cell lines (MHCC97-L, HMCC97-H, and HCCLM3) with increasing spontaneous metastatic potential. Now, the fourth cell line with unique multiple metastatic characteristics has been established by six rounds of in vivo selection.

Results

This cell line, designated as HCCLM6, is a polygonal epithelial cell with hypotriploid karyotype, the modal chromosomes are 55-58, and marker chromosomal abnormalities include i(1) (q10), i(8)(q10), der (4) t(4;8)(q31;q22), i(X)(q10). The cell population doubling time was 32 h. Fluorescent PCR showed HBV DNA integration in the cellular genome. Thirty-five days after HCCLM6 was injected subcutaneously into BALB/c nude mice, prominent lung metastases occurred in 100% of the recipient animals. When tumor tissue was orthotopically implanted into the liver of nude mouse, widespread loco-regional and pulmonary metastases occurred. Inoculation of this cell into the footpad of nude mice also produced 75% regional lymph node metastasis. Compared with MHCC97-L which was not metastastatic via subcutaneous or footpad inoculation and 40% metastatic via orthotopic inoculation, HCCLM6 had increased expression of matrix metalloproteinase (MMP-2 and MMP-9) and cytokeratin 19 (CK19), and decreased expression of Rb2/p130. The establishment of this new cell line has completed our stepwise metastatic HCC cell mode system, which was characterized by a similar genetic background but with significant differences in spontaneous metastasis behavior.

Conclusions

The study supports the theory that cancer metastasis is a highly selective dynamic process and the cell model system could be a useful platform for the study of HCC metastasis.
Literatur
Zurück zum Zitat Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239–3245PubMed Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239–3245PubMed
Zurück zum Zitat Baldi A, Esposito V, De Luca A, Fu Y, Meoli I, Giordano GG, Caputi M, Baldi F, Giordano A (1997) Differential expression of Rb2/p130 and p107 in normal human tissue and in primary lung cancer. Clin Cancer Res 3:1691–1697PubMed Baldi A, Esposito V, De Luca A, Fu Y, Meoli I, Giordano GG, Caputi M, Baldi F, Giordano A (1997) Differential expression of Rb2/p130 and p107 in normal human tissue and in primary lung cancer. Clin Cancer Res 3:1691–1697PubMed
Zurück zum Zitat Chu YW, Runyan RB, Oshima RG, Hendrix MJ (1993) Expression of of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc Natl Acad Sci USA 90:4261–4265PubMed Chu YW, Runyan RB, Oshima RG, Hendrix MJ (1993) Expression of of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc Natl Acad Sci USA 90:4261–4265PubMed
Zurück zum Zitat Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY, Xia QC (2004a) Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 4:982–994CrossRefPubMed Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY, Xia QC (2004a) Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 4:982–994CrossRefPubMed
Zurück zum Zitat Ding SJ, Li Y, Tan YX, Jian MR, Tian B, Liu YK, Shao XX., Ye SL, Wu JR, Zeng R, Wang HY, Tang ZY, Xia QC (2004b) From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics 3:73–81CrossRefPubMed Ding SJ, Li Y, Tan YX, Jian MR, Tian B, Liu YK, Shao XX., Ye SL, Wu JR, Zeng R, Wang HY, Tang ZY, Xia QC (2004b) From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics 3:73–81CrossRefPubMed
Zurück zum Zitat Eyken van P, Sciot R, Callea F, Ramaekers F, Schaart C, Desmet VJ (1990) A cytokeratin-immunohistological study of hepatocellular carcinoma. Hum Pathol 21:302–308PubMed Eyken van P, Sciot R, Callea F, Ramaekers F, Schaart C, Desmet VJ (1990) A cytokeratin-immunohistological study of hepatocellular carcinoma. Hum Pathol 21:302–308PubMed
Zurück zum Zitat Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res 50:6130–6138PubMed Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res 50:6130–6138PubMed
Zurück zum Zitat Fidler IJ (2002a) Critical determinants of metastasis. Semi Cancer Biol 12:89–96CrossRef Fidler IJ (2002a) Critical determinants of metastasis. Semi Cancer Biol 12:89–96CrossRef
Zurück zum Zitat Fidler IJ, Kripke ML (2003) Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat Genet 34:23CrossRef Fidler IJ, Kripke ML (2003) Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat Genet 34:23CrossRef
Zurück zum Zitat Giannelli G, Bergamini C, Marinosci F, Fransvea E, Quaranta M, Lupo L, Schiraldi O, Antonaci S (2002) Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer 97:425–431CrossRefPubMed Giannelli G, Bergamini C, Marinosci F, Fransvea E, Quaranta M, Lupo L, Schiraldi O, Antonaci S (2002) Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer 97:425–431CrossRefPubMed
Zurück zum Zitat Hannon GJ, Demetrick D, Beach D (1993) Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7:2378–2391PubMed Hannon GJ, Demetrick D, Beach D (1993) Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7:2378–2391PubMed
Zurück zum Zitat Kim JH, Kim TH, Jang JW, Jang YJ, Lee KH, Lee ST (2001) Analysis of matrix metalloproteinase mRNAs expressed in hepatocellular carcinoma cell lines. Mol Cells 12:32–40PubMed Kim JH, Kim TH, Jang JW, Jang YJ, Lee KH, Lee ST (2001) Analysis of matrix metalloproteinase mRNAs expressed in hepatocellular carcinoma cell lines. Mol Cells 12:32–40PubMed
Zurück zum Zitat Kleiner DE, Stetler-Stevenson WG (1994) Quantitative zymograpy: detection of pictogram quantities of gelatinases. Anal Biochem 218:325–329CrossRefPubMed Kleiner DE, Stetler-Stevenson WG (1994) Quantitative zymograpy: detection of pictogram quantities of gelatinases. Anal Biochem 218:325–329CrossRefPubMed
Zurück zum Zitat Leoncini L, Bellan C, Cossu A, Claudio PP, Lazzi S, Cinti C, Cevenini G, Megha T, Laurini L, Luzi P, Orcioni GF, Piccioli M, Pileri S, Giardino C, Tosi P, Giordano A (1999) Retinoblatoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control. Clin Cancer Res 5:4065–4072PubMed Leoncini L, Bellan C, Cossu A, Claudio PP, Lazzi S, Cinti C, Cevenini G, Megha T, Laurini L, Luzi P, Orcioni GF, Piccioli M, Pileri S, Giardino C, Tosi P, Giordano A (1999) Retinoblatoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control. Clin Cancer Res 5:4065–4072PubMed
Zurück zum Zitat Li Y, Graham C, Lacy S, Duncan AM, Whyte P (1993) The adnovirus E1A-associated 130-kD protein is encoded by a member of the retinoblasoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366–2377PubMed Li Y, Graham C, Lacy S, Duncan AM, Whyte P (1993) The adnovirus E1A-associated 130-kD protein is encoded by a member of the retinoblasoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366–2377PubMed
Zurück zum Zitat Li Y, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q, Chen J, Gao DM, Bao WH (2001) Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 7:630–636PubMed Li Y, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q, Chen J, Gao DM, Bao WH (2001) Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 7:630–636PubMed
Zurück zum Zitat Li Y, Tang ZY, Ye SL, Liu BB, Liu YK, Chen J, Xue Q (2003) Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screen for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 129:43–51 Li Y, Tang ZY, Ye SL, Liu BB, Liu YK, Chen J, Xue Q (2003) Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screen for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 129:43–51
Zurück zum Zitat Liao Y, Tang ZY, Ye SL, Liu KD, Sun FX, Huang Z (2000) Modulation of apoptosis, tumorigenecity and metastatic potential with antisense H-ras oligodeoxynucleotides in a highly metastatic tumor model of hepatoma: LCI-D20. Gastroenterol Hepatol 47:365–370 Liao Y, Tang ZY, Ye SL, Liu KD, Sun FX, Huang Z (2000) Modulation of apoptosis, tumorigenecity and metastatic potential with antisense H-ras oligodeoxynucleotides in a highly metastatic tumor model of hepatoma: LCI-D20. Gastroenterol Hepatol 47:365–370
Zurück zum Zitat Massaro-Giordano M, Baldi G, De Luca A, Baldi A, Giordano A (1999) Differential expression of the retinoblasoma gene family members in chorodial melanoma: prognostic significance. Clin Cancer Res 5:1455–1458PubMed Massaro-Giordano M, Baldi G, De Luca A, Baldi A, Giordano A (1999) Differential expression of the retinoblasoma gene family members in chorodial melanoma: prognostic significance. Clin Cancer Res 5:1455–1458PubMed
Zurück zum Zitat McKenna GJ, Chen Y, Smith RM, Meneghetti A, Ong C, McMaster R, Scudamore CH, Chung SW (2002) A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas. Am J Surg 183:588–594CrossRefPubMed McKenna GJ, Chen Y, Smith RM, Meneghetti A, Ong C, McMaster R, Scudamore CH, Chung SW (2002) A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas. Am J Surg 183:588–594CrossRefPubMed
Zurück zum Zitat Milde-Langosch K, Goemann C, Methner C, Rieck G, Bamberger AM, Loning T (2001) Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status. Br J Cancer 85:546–551CrossRefPubMed Milde-Langosch K, Goemann C, Methner C, Rieck G, Bamberger AM, Loning T (2001) Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status. Br J Cancer 85:546–551CrossRefPubMed
Zurück zum Zitat Paggi MG, Giordano A (2001) Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother. Cancer Res 61:4651–4654PubMed Paggi MG, Giordano A (2001) Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother. Cancer Res 61:4651–4654PubMed
Zurück zum Zitat Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18–29CrossRefPubMed Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18–29CrossRefPubMed
Zurück zum Zitat Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49–54CrossRefPubMed Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49–54CrossRefPubMed
Zurück zum Zitat Stosiek P, Kasper M, Karsten U (1990) Expression of cytokeratin 19 during human liver organogenesis. Liver 10:59–63PubMed Stosiek P, Kasper M, Karsten U (1990) Expression of cytokeratin 19 during human liver organogenesis. Liver 10:59–63PubMed
Zurück zum Zitat Sun FX, Tang ZY, Liu KD, Ye SL, Xue Q, Gao DM, Ma ZC (1996) Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer 66:239–243CrossRefPubMed Sun FX, Tang ZY, Liu KD, Ye SL, Xue Q, Gao DM, Ma ZC (1996) Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer 66:239–243CrossRefPubMed
Zurück zum Zitat Tabor E (2001) Hepatocellular carcinoma: global epidemiology. Digest Liver Dis 33:115–117CrossRef Tabor E (2001) Hepatocellular carcinoma: global epidemiology. Digest Liver Dis 33:115–117CrossRef
Zurück zum Zitat Tanaka N, Odajima T, Nakano T, Kimijima Y, Yamada S, Ogi K, Kohama G (1999) Immunohistochemical investigation of new suppressor oncogene p130 in oral squamous cell carcinoma. Oral Oncol 35:321–325CrossRefPubMed Tanaka N, Odajima T, Nakano T, Kimijima Y, Yamada S, Ogi K, Kohama G (1999) Immunohistochemical investigation of new suppressor oncogene p130 in oral squamous cell carcinoma. Oral Oncol 35:321–325CrossRefPubMed
Zurück zum Zitat Tang ZY (2000) Surgery of hepatocellular carcinoma with special reference to studies on metastasis and recurrence. Gastroenterol Today 4:191–195 Tang ZY (2000) Surgery of hepatocellular carcinoma with special reference to studies on metastasis and recurrence. Gastroenterol Today 4:191–195
Zurück zum Zitat Tang ZY (2001) Hepatocellular carcinoma–cause, treatment and metastasis. World J Gastroenterol 7:445–454PubMed Tang ZY (2001) Hepatocellular carcinoma–cause, treatment and metastasis. World J Gastroenterol 7:445–454PubMed
Zurück zum Zitat Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q (1999) New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer 81:814–821PubMed Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q (1999) New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer 81:814–821PubMed
Zurück zum Zitat Theret N, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, Campion JP, Boudjema K, Clement B (2001) Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 34:82–88CrossRefPubMed Theret N, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, Campion JP, Boudjema K, Clement B (2001) Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 34:82–88CrossRefPubMed
Zurück zum Zitat Wu PC, Fang JWS, Lau VKT, Lai CL, Lo CK, Lau JYN (1996) Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Am J Pathol 149:1167–1175PubMed Wu PC, Fang JWS, Lau VKT, Lai CL, Lo CK, Lau JYN (1996) Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Am J Pathol 149:1167–1175PubMed
Zurück zum Zitat Yeung RS, Bell DW, Testa JR, Mayol X, Baldi A, Grana X, Klinga-Levan K, Knudson AG, Giordano A (1993) The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene 8:3465–3468PubMed Yeung RS, Bell DW, Testa JR, Mayol X, Baldi A, Grana X, Klinga-Levan K, Knudson AG, Giordano A (1993) The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene 8:3465–3468PubMed
Zurück zum Zitat Zamparelli A, Masciullo V, Bovicelli A, Santini D, Ferrandina G, Minimo C, Terzano P, Costa S, Cinti C, Ceccarelli C, Mancuso S, Scambia G, Bovicelli L, Giordano A (2001) Expression of cell-cycle-associated proteins pRb2/p130 and p27kip1 in vulvar squamous cell carcinomas. Hum Pathol 32:4–9CrossRefPubMed Zamparelli A, Masciullo V, Bovicelli A, Santini D, Ferrandina G, Minimo C, Terzano P, Costa S, Cinti C, Ceccarelli C, Mancuso S, Scambia G, Bovicelli L, Giordano A (2001) Expression of cell-cycle-associated proteins pRb2/p130 and p27kip1 in vulvar squamous cell carcinomas. Hum Pathol 32:4–9CrossRefPubMed
Metadaten
Titel
Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics
verfasst von
Yan Li
Bo Tian
Jiong Yang
Lei Zhao
Xin Wu
Sheng-Long Ye
Yin-Kun Liu
Zhao-You Tang
Publikationsdatum
01.08.2004
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 8/2004
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-004-0564-9

Weitere Artikel der Ausgabe 8/2004

Journal of Cancer Research and Clinical Oncology 8/2004 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.